Paul Kudelko, DO
Cardiovascular Disease · Hendersonville, TNNPI 1225027014
Payments from drug & device makers
Across 460 payments — averaging $338.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$147K
- Johnson & Johnson$2K
- Amgen$1K
- Inari Medical, Inc.$886
- Pfizer$439
- Shockwave Medical, Inc$438
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 103 | $146,806 |
| Johnson & Johnson | 77 | $1,756 |
| Amgen | 46 | $1,327 |
| Inari Medical, Inc. | 6 | $886 |
| Pfizer | 31 | $439 |
| Shockwave Medical, Inc | 4 | $438 |
| Abbott | 3 | $421 |
| Novartis | 28 | $409 |
| Boston Scientific | 18 | $405 |
| E.r. Squibb & Sons, L.L.C. | 28 | $380 |
| AstraZeneca | 19 | $295 |
| Boehringer Ingelheim | 13 | $275 |
| Actelion Pharmaceuticals US, Inc. | 12 | $228 |
| Bayer | 6 | $227 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $165 |
| Inquis Medical, Inc. | 1 | $158 |
| Merck | 6 | $129 |
| Kiniksa Pharmaceuticals, Ltd. | 7 | $118 |
| Baxter Healthcare | 5 | $94 |
| Amarin Pharma, Inc. | 5 | $84 |
| Esperion Therapeutics, Inc. | 4 | $80 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $54 |
| Astellas Pharma US Inc | 3 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Lilly USA, LLC | 2 | $45 |
| Lundbeck LLC | 3 | $41 |
| Abiomed | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Portola Pharmaceuticals, LLC | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Acist Medical Systems, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Surmodics, Inc. | 1 | $23 |
| Celonova Biosciences, Inc. | 1 | $20 |
| Cardiac Dimensions, Inc. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Cashflow Solutions, LLC | 1 | $9 |
How this compares
$155,631 in reported general payments places this provider in the 90th percentile of 429 cardiovascular disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Hendersonville
- Albert KochHendersonville$154K
- Brian LindmanNashville$5.5M
- David MetzgerKingsport$4.8M
- Christopher EllisNashville$4.1M
- Dinesh GuptaNashville$3.2M
- Joann LindenfeldNashville$2.2M
- Frank McGrewMemphis$2.1M
- Rebecca HungNashville$1.8M
- Mohsin AlhaddadJackson$1.8M
- Robert SmithBrentwood$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.